Description
SLU-PP-332 is a small-molecule estrogen-related receptor pan-agonist activating ERRalpha, ERRbeta, and ERRgamma. Nuclear receptors that co-activate PGC-1alpha to drive mitochondrial biogenesis, fatty acid oxidation gene expression, and oxidative metabolism programs. As a small molecule with documented oral bioavailability in preclinical models, the SLU-PP-332 capsules are appropriate for research examining ERR nuclear receptor activation through oral administration protocols.
Storage and Handling
Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. Refer to the lot-specific certificate of analysis for recommended storage conditions.
Compliance Notice
SLU-PP-332 capsules are for laboratory research use only. They are not for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. FDA has not evaluated this product. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.
